FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Galina Yamshchikov

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Genes & Molecular Sequences

Amino Acid Sequences

Concepts & Ideas

Procedures

Neutralization Tests

Co-author Network

Publications

TOP 3
Victoria Borisevich; Ryan Nistler; D Hudman; Galina V Yamshchikov; Alexey Seregin; Vladimir Yamshchikov
A highly sensitive and versatile virus titration assay in the 96-well microplate format.
Craig L Slingluff; Gina R Petroni; Kimberly A Chianese-Bullock; Mark E Smolkin; Sarah Hibbitts; Cheryl Murphy; Naomi Johansen; William W Grosh; Galina V Yamshchikov; Patrice Y Neese; James W Patterson; Robyn Fink; Patrice K Rehm
Immunologic and clinical outcomes of a randomized phase II trial of two multipeptide vaccines for melanoma in the adjuvant setting.
Alexey Seregin; Ryan Nistler; Victoria Borisevich; Galina V Yamshchikov; Elena Chaporgina; Chun Wai Kwok; Vladimir Yamshchikov
Immunogenicity of West Nile virus infectious DNA and its noninfectious derivatives.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Galina Yamshchikov (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Victoria Borisevich; Ryan Nistler; D Hudman; Galina V Yamshchikov; Alexey Seregin; Vladimir Yamshchikov
A highly sensitive and versatile virus titration assay in the 96-well microplate format.
Journal of virological methods 2008;147(2):197-205.
2007: Craig L Slingluff; Gina R Petroni; Kimberly A Chianese-Bullock; Mark E Smolkin; Sarah Hibbitts; Cheryl Murphy; Naomi Johansen; William W Grosh; Galina V Yamshchikov; Patrice Y Neese; James W Patterson; Robyn Fink; Patrice K Rehm
Immunologic and clinical outcomes of a randomized phase II trial of two multipeptide vaccines for melanoma in the adjuvant setting.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(21):6386-95.
2006: Alexey Seregin; Ryan Nistler; Victoria Borisevich; Galina V Yamshchikov; Elena Chaporgina; Chun Wai Kwok; Vladimir Yamshchikov
Immunogenicity of West Nile virus infectious DNA and its noninfectious derivatives.
Virology 2006;356(1-2):115-25.
2006: Chien-Chung Chang; Takeshi Ogino; David W Mullins; Janine L Oliver; Galina V Yamshchikov; Nobuyuki Bandoh; Craig L Slingluff; Soldano Ferrone
Defective human leukocyte antigen class I-associated antigen presentation caused by a novel beta2-microglobulin loss-of-function in melanoma cells.
The Journal of biological chemistry 2006;281(27):18763-73.
2005: William Chad Cragun; Galina V Yamshchikov; Eric A Bissonette; Mark E Smolkin; Shannon Eastham; Gina R Petroni; Randy S Schrecengost; Elizabeth M H Woodson; Craig L Slingluff
Low-dose IL-2 induces cytokine cascade, eosinophilia, and a transient Th2 shift in melanoma patients.
Cancer immunology, immunotherapy : CII 2005;54(11):1095-105.
2005: Galina V Yamshchikov; Victoria Borisevich; Chun Wai Kwok; Ryan Nistler; Jake Kohlmeier; Alexey Seregin; Elena Chaporgina; Stephen H Benedict; Vladimir Yamshchikov
The suitability of yellow fever and Japanese encephalitis vaccines for immunization against West Nile virus.
Vaccine 2005;23(39):4785-92.
2005: Galina V Yamshchikov; David W Mullins; Chien-Chung Chang; Takeshi Ogino; Lee Thompson; Jennifer Presley; Holly Galavotti; William Aquila; Donna H Deacon; William Ross; James W Patterson; Victor H Engelhard; Soldano Ferrone; Craig L Slingluff
Sequential immune escape and shifting of T cell responses in a long-term survivor of melanoma.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(11):6863-71.
2005: Kimberly A Chianese-Bullock; Jennifer Ghith; Courtney F Garbee; Sarah Hibbitts; Cheryl Murphy; Galina V Yamshchikov; Gina R Petroni; Eric A Bissonette; Patrice Y Neese; William W Grosh; Priscilla Merrill; Robyn Fink; Elizabeth M H Woodson; Catherine J Wiernasz; James W Patterson; Craig L Slingluff
MAGE-A1-, MAGE-A10-, and gp100-derived peptides are immunogenic when combined with granulocyte-macrophage colony-stimulating factor and montanide ISA-51 adjuvant and administered as part of a multipeptide vaccine for melanoma.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(5):3080-6.
2004: Galina V Yamshchikov; Victoria Borisevich; Alexey Seregin; Elena Chaporgina; Margarita Mishina; Vasiliy Mishin; Chun Wai Kwok; Vladimir Yamshchikov
An attenuated West Nile prototype virus is highly immunogenic and protects against the deadly NY99 strain: a candidate for live WN vaccine development.
Virology 2004;330(1):304-12.
2004: Craig L Slingluff; Gina R Petroni; Galina V Yamshchikov; Sarah Hibbitts; William W Grosh; Kimberly A Chianese-Bullock; Eric A Bissonette; Donna L Barnd; Donna H Deacon; James W Patterson; Jaysheree Parekh; Patrice Y Neese; Elizabeth M H Woodson; Catherine J Wiernasz; Priscilla Merrill
Immunologic and clinical outcomes of vaccination with a multiepitope melanoma peptide vaccine plus low-dose interleukin-2 administered either concurrently or on a delayed schedule.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(22):4474-85.
2003: Craig L Slingluff; Gina R Petroni; Galina V Yamshchikov; Donna L Barnd; Shannon Eastham; Holly Galavotti; James W Patterson; Donna H Deacon; Sarah Hibbitts; David Teates; Patrice Y Neese; William W Grosh; Kimberly A Chianese-Bullock; Elizabeth M H Woodson; Catherine J Wiernasz; Priscilla Merrill; Jennifer Gibson; Maureen Ross; Victor H Engelhard
Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(21):4016-26.
2001: Craig L Slingluff; Galina V Yamshchikov; Patrice Y Neese; Holly Galavotti; Shannon Eastham; Victor H Engelhard; DJ Kittlesen; Donna H Deacon; Sarah Hibbitts; William W Grosh; Gina R Petroni; R Cohen; Catherine J Wiernasz; James W Patterson; Brian P Conway; William G Ross
Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(10):3012-24.
2001: Galina V Yamshchikov; Donna L Barnd; Shannon Eastham; Holly Galavotti; James W Patterson; Donna H Deacon; D Teates; Patrice Y Neese; William W Grosh; Gina R Petroni; Victor H Engelhard; Craig L Slingluff
Evaluation of peptide vaccine immunogenicity in draining lymph nodes and peripheral blood of melanoma patients.
International journal of cancer. Journal international du cancer 2001;92(5):703-11.
2001: Galina V Yamshchikov; Lee Thompson; William G Ross; Holly Galavotti; W Aquila; Donna H Deacon; J Caldwell; James W Patterson; Donald F Hunt; Craig L Slingluff
Analysis of a natural immune response against tumor antigens in a melanoma survivor: lessons applicable to clinical trial evaluations.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3 Suppl):909s-916s.
1999: Laurence H Brinckerhoff; V V Kalashnikov; Lee W Thompson; Galina V Yamshchikov; Richard A Pierce; Holly Galavotti; Victor H Engelhard; Craig L Slingluff
Terminal modifications inhibit proteolytic degradation of an immunogenic MART-1(27-35) peptide: implications for peptide vaccines.
International journal of cancer. Journal international du cancer 1999;83(3):326-34.